about
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trialsCirculating tumor cells: cornerstone of personalized medicineReal-time liquid biopsy: circulating tumor cells versus circulating tumor DNA.Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patientsCancer micrometastases.Clinical relevance and biology of circulating tumor cells.Current status in human breast cancer micrometastasis.Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevanceCirculating tumor cells and bone marrow micrometastasis.Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer.Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies.Circulating tumour cells in cancer patients: challenges and perspectives.Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.Circulating tumor cells and circulating tumor DNA.EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients.Plasticity of disseminating cancer cells in patients with epithelial malignancies.Circulating tumor cells: liquid biopsy of cancer.Real-time liquid biopsy in cancer patients: fact or fiction?Technologies for detection of circulating tumor cells: facts and vision.Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair.Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay.Functional studies on circulating and disseminated tumor cells in carcinoma patientsClinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.Frequent expression of PD-L1 on circulating breast cancer cells.Establishment and characterization of a cell line from human circulating colon cancer cells.Epithelial-mesenchymal plasticity in circulating tumor cells.Characterization of single circulating tumor cells.Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients.Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.Cell lines from circulating tumor cells.Liquid biopsy: Potential and challenges.Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients.Capture of viable circulating tumor cells in the liver of colorectal cancer patients.Molecular mechanisms of metastasis.Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.EpCAM-Independent Enrichment and Detection of Viable Circulating Tumor Cells Using the EPISPOT Assay.Detection of Circulating Plasma Cells in Multiple Myeloma.Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma.Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
P50
Q26827936-1FA6D141-B370-4A75-9A2F-B0B985589BADQ26864541-F201EFD8-B021-4F6C-B776-88128CFE5CDCQ34357786-F85E0374-638D-41A1-8720-0FB79767EC18Q34547042-ED9B0871-79E1-44B9-AC8C-281E612255D2Q34978121-8FA6B30D-FDEB-49A8-B78B-4A27D8C8B964Q35889548-52D7E924-4784-4EEE-8EDF-31BD041A023DQ36956081-EB347DC3-C347-43F3-9CBB-4FE5C4C7F1D3Q37019257-3BA6A012-9067-4E27-9F70-EC1E16DDE88DQ37242269-C676171F-2311-4A5E-897B-5345A1616457Q37277185-9377258B-E52B-4479-8AE1-BA8213814AE3Q37667085-90024C61-3839-4070-B783-67EBEF9332C6Q37720117-8BE80702-FE79-44F1-B1EE-257AFBECCEB2Q37776363-3DDA18C2-C592-4950-B460-0DA528BB9112Q37890657-FD2A35E5-B888-48C9-8555-FE1F26464A17Q37952771-14359A26-F42D-47A4-815C-3089F8A7D89BQ38004890-A1549AEA-B42F-406A-AD82-D49CEE9972DBQ38021683-40A1FADB-6326-4C7A-936E-C3D30279D9C8Q38046735-DA55A929-FFEB-4B99-9335-95CC697AA088Q38154437-800F967E-FC4B-40D9-B117-A2D4F3083F1BQ38154493-78A5F2B8-F223-42F6-BF35-4A15251B3F6EQ38289630-C0B26C07-23E5-462A-8105-C0D211C826F5Q38590310-1479DAE5-75E5-4BA3-9402-A99A97DC8DE4Q38723767-ACE289C5-F192-45E6-B868-3817D2B53C65Q38771051-38B6AF86-72DF-447A-B0A8-F1562F4A4A98Q38861829-119E0F73-3359-4229-9B67-8924ACC9AEF0Q38919576-9990499D-6E17-4672-BF90-18229994E32DQ39053335-79CE7BDC-EC82-4048-9C70-196D6A6DD33BQ39275082-010AEC00-F9EB-4C64-9E0A-81DE6807ABADQ39612538-BCEDFEE7-1241-4333-A130-05398E4E259BQ40417804-22422363-158E-4E00-896E-793AC3E3DF62Q42135712-CC55A963-BC61-472B-A212-64889F902CBEQ42337624-18358BC9-2DE4-4D39-8CD5-DB7B5E1BD48FQ44115632-8D75D43A-1399-450F-9DF2-1F6C27EC8A27Q45819007-D3170014-3D67-449D-83E3-159FBF2C0290Q46055814-445E9AD5-646B-4923-99A3-6396ECF962A8Q47419489-2E5D1860-AB4E-4E06-A47D-20E489842E9EQ47936698-45F1C100-3EE2-41DA-8CA0-DBD048C0179DQ50035177-085C262A-330E-4AE0-8EB8-A7A8AEDAEF74Q53097632-0B6D2C01-C407-49EA-80D7-3C68886136ABQ54769141-3D12F909-89F5-41A8-BA5F-27CED2024E59
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Catherine Alix-Panabières
@ast
Catherine Alix-Panabières
@en
Catherine Alix-Panabières
@es
Catherine Alix-Panabières
@nl
Catherine Alix-Panabières
@sl
type
label
Catherine Alix-Panabières
@ast
Catherine Alix-Panabières
@en
Catherine Alix-Panabières
@es
Catherine Alix-Panabières
@nl
Catherine Alix-Panabières
@sl
prefLabel
Catherine Alix-Panabières
@ast
Catherine Alix-Panabières
@en
Catherine Alix-Panabières
@es
Catherine Alix-Panabières
@nl
Catherine Alix-Panabières
@sl
P106
P21
P31
P496
0000-0002-6401-2903